| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |